Collaboration enables direct integration of DataHow's digital solutions with Genedata's platform, accelerating the development of next-generation biotherapeutics DataHow's platform provides ...
To ensure a biomanufacturing process is consistent and efficient, scientists use a statistical analysis technique called design-of-experiment (DoE) to understand the relationship between the materials ...
Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes. Through this collaboration, Axio BioPharma will ...
SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies, and Chime Biologics, a global leading contract development and manufacturing organization (CDMO ...
The importance of Fc glycosylation of monoclonal antibodies (mAbs) with regard to biological activity is widely discussed and has been investigated in numerous studies. It is known that different ...
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced it has entered into an agreement with KBI Biopharma, Inc. (“KBI”) for the process ...
In industrial engineering, digital twins—computer models of systems or processes—let scientists try out ideas before finalizing designs. In addition, on the factory floor, twins can model processes in ...
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
WESTMINSTER, Colo., May 28, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced a new development program to evaluate AB201 (rNAPc2), a potent, selective inhibitor of tissue ...
MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from ...
EDINBURGH, Scotland, April 6, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback